B
Bozhen Biotechnology Zhejiang
Innovative organoid culture solutions for precise and reproducible biomedical research
About Bozhen Biotechnology Zhejiang
BioGenous is a biotechnology company specializing in the development and commercialization of advanced organoid culture systems. These systems are designed to provide researchers with precise and reproducible tools for studying human diseases, particularly cancer. BioGenous serves academic institutions, pharmaceutical companies, and clinical research organizations, operating within the biomedical research market. The company's business model revolves around the sale of specialized kits and reagents that enable the growth and maintenance of organoids, which are three-dimensional cell cultures that mimic the structure and function of human organs. By offering these products, BioGenous generates revenue through direct sales and long-term supply agreements with research entities. The company's innovative solutions allow for more consistent cell growth and reproducible experiments, making it a valuable partner in the quest for medical breakthroughs.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 19.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2024 | $2.8M | $69M | AstraZeneca | ↗ |
| SERIES A✓Equity / VC | Jan 2023 | $14M | $55M | State Development & Investment Corporation (SDIC) · Marathon Venture Partners | ↗ |
Growth signals
Latest recorded traffic for Bozhen Biotechnology Zhejiang is 150 monthly website visits, up 0% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Bozhen Biotechnology Zhejiang in its local ecosystem
The Bozhen Biotechnology Zhejiang office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
State Development & Investment Corporation (SDIC)- MPMarathon Venture Partners
AstraZeneca
Other known investors1 additional known investor
Tsinghua University
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bozhen Biotechnology Zhejiang on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bozhen Biotechnology Zhejiang’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








